Northside Capital Management’s Biogen BIIB Stock Holding History

Northside Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-797	Closed	-$226K	–	94
2020 Q3	$226K	Hold	797	–	–	0.07%	79
2020 Q2	$213K	Hold	797	–	–	0.07%	90
2020 Q1	$252K	Hold	797	–	–	0.12%	65
2019 Q4	$236K	Buy	+797	New	+$221K	0.08%	85
2019 Q2	–	Sell	-852	Closed	-$201K	–	64
2019 Q1	$201K	Hold	852	–	–	0.08%	59
2018 Q4	$256K	Hold	852	–	–	0.11%	51
2018 Q3	$301K	Hold	852	–	–	0.11%	50
2018 Q2	$247K	Hold	852	–	–	0.09%	58
2018 Q1	$233K	Hold	852	–	–	0.08%	62
2017 Q4	$271K	Hold	852	–	–	0.08%	59
2017 Q3	$267K	Hold	852	–	–	0.11%	53
2017 Q2	$231K	Hold	852	–	–	0.1%	57
2017 Q1	$233K	Hold	852	–	–	0.06%	115
2016 Q4	$242K	Hold	852	–	–	0.09%	55
2016 Q3	$267K	Hold	852	–	–	0.1%	56
2016 Q2	$206K	Hold	852	–	–	0.1%	62
2016 Q1	$222K	Buy	+852	New	+$225K	0.14%	62

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Northside Capital Management's BIIB Position: Q4 2020 in Review

Northside Capital Management sold out of Biogen (BIIB) in Q4 2020, closing a stake of 797 shares — an estimated $226K sold.

Northside Capital Management first reported a position in BIIB in Q1 2016 and held it in 17 quarters. The position peaked at $301K in Q3 2018. 1,062 funds tracked by Wall St. Rank hold BIIB as of Q4 2020.

Northside Capital Management reported no remaining Biogen position as of Q4 2020 after selling out during the quarter.
Northside Capital Management sold 797 Biogen shares in Q4 2020, an estimated $226K.
Northside Capital Management first reported a position in Biogen in Q1 2016 and held it in 17 quarters.
Northside Capital Management's Biogen position peaked at $301K in Q3 2018.
1,062 funds tracked by Wall St. Rank held Biogen as of Q4 2020.

Based on Northside Capital Management's 13F filing for Q4 2020, filed 22 Jan 2021.